Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

philips electronics australia ltd - 45143 - combination diagnostic imaging system, pet/ct - a diagnostic imaging system that combines positron emission tomography (pet) and x-ray computed tomography (ct) systems. the ct subsystem produces cross-sectional images of the body by computer reconstruction of x-ray transmission data. the pet subsystem produces images of the distribution of pet radiopharmaceuticals in the patient body (specific radiopharmaceuticals are used for whole body, brain, heart and other organ imaging). ct data is applied to the pet data for attenuation correction. the pet subsystem also provides for list mode, dynamic, and gated acquisitions.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

vicki partridge pty ltd - 17929 - analyser, physiologic, neuromuscular function - the device is intended to monitor physical motion and muscle activity to quantify kinematics of movement disorder symptoms such as tremor and assess activity in any instance where quantifiable analysis of motion and muscle activity is desired.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

esposito consulting services pty ltd - 44785 - compression system pump, sequential - the lymphastim is used to provide lymphatic drainage that unblocks the lymphatic ducts and vessels. this causes a natural flow of the lymph from the peripheral parts of the body, thus it reduces swelling and pain caused by the excessive amount oof lymph and metabolites in the limb.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

bk medical australia pty ltd - 41670 - radiology picture archiving and communication system application software - mim software is intended for trained medical professionals including, but not limited to, radiologists, oncologists, physicians, medical technologists, dosimetrists and physicists. mim is a medical image and information management system that is intended to receive, transmit, store, retrieve, display, print and process digital medical images, as well as create, display and print reports from those images. the medical modalities of these medical imaging systems include, but are not limited to, ct, mri, cr, dx, mg, us, spect, pet and xa as supported by acr/nema dicom 3.0. mim provides the user with the means to display, register and fuse medical images from multiple modalities. mim provides tools to quickly create, transform, and modify contours for applications including, but not limited to, quantitative analysis, aiding adaptive therapy, transferring contours to radiation therapy treatment planning systems and archiving contours for patient follow- up and management. mim allows the dose distribution of an implant to be individually shaped for each patient and is a general purpose brachytherapy planning system used for prospective and confirmation dose calculations for patients undergoing a course of brachytherapy using permanent implants of various radioisotopes.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

nl-tec pty ltd - 41670 - radiology picture archiving and communication system application software - mim software is intended for trained medical professionals including, but not limited to, radiologists, oncologists, physicians, medical technologists, dosimetrists and physicists. mim is a medical image and information management system that is intended to receive, transmit, store, retrieve, display, print and process digital medical images, as well as create, display and print reports from those images. the medical modalities of these medical imaging systems include, but are not limited to, ct, mri, cr, dx, mg, us, spect, pet and xa as supported by acr/nema dicom 3.0. mim provides the user with the means to display, register and fuse medical images from multiple modalities. additionally, it evaluates cardiac left ventricular function and perfusion, including left ventricular end-diastolic volume, end-systolic volume, and ejection fraction. the region of interest (roi) feature reduces the time necessary for the user to define objects in medical image volumes by providing an initial definition of object contours. the objects include, but are not limited to, tumors and normal tissues. mim provides tools to quickly create, transform, and modify contours for applications including, but not limited to, quantitative analysis, aiding adaptive therapy, transferring contours to radiation therapy treatment planning systems and archiving contours for patient follow-up and management. mim aids in the assessment of pet/spect brain scans. it provides automated quantitative and statistical analysis by automatically registering pet/spect brain scans to a standard template and comparing intensity values to a reference database or to other pet/spect scans on a voxel by voxel basis, within stereotactic surface projections or standardized regions of interest.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 35313 - retractor, cardiovascular - instrument for retracting soft tissue during medical/surgical procedures.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rx pharma-pack, inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride anhydrous 5 mg in 1 ml - marcaine is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of marcaine in these patients. marcaine is not recommended for intravenous regional anesthesia (bier block). see warnings . the routes of administration and indicated marcaine concentrations are: - local infiltration - peripheral nerve block - retrobulbar block - sympathetic block - lumbar epidural  0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) - caudal - epidural test dose - dental blocks (see dosage and administration for additional information). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of mar

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rx pharma-pack, inc. - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 40 mg in 1 ml - a. for intramuscular administration when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of depo-medrol sterile aqueous suspension is indicated as follows: allergic states : control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders : primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of par

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rx pharma-pack, inc. - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 40 mg in 1 ml - a. for intramuscular administration when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of depo-medrol sterile aqueous suspension is indicated as follows: allergic states : control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases : bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders : primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of par

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

health care laboratories inc. - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 0.03 g in 1 g - description:  bioflexor® gel is an otc topical analgesic preparation which delivers deep penetrating, effective pain relief.  bioflexor® is a unique product from several viewpoints.  in developing bioflexor®, our main focus was to formulate a potent topical analgesic agent that would minimize the need for oral narcotic analgesics.  the result is an exceptional product that truly helps those individuals suffering from the pain associated with the spectrum of medical conditions from arthritis to muscle aches and pain, simple back aches, strains, bruises, and sprains.  menthol is the only listed active ingredient on the bioflexor® label.  the other all natural components work synergistically to produce the pain relieving activity.  another unique aspect of bioflexor® relates to the immediate and long-lasting pain relief without the side effects of lingering scent (methyl salicylate rubs, ie. ben gay), burning sensation (capsaicin ie. zostrix, theragesic, icy-hot), greasy residue (ie. aspercreme, be